Literature DB >> 3880553

Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis.

R H Wiesner, N F LaRusso, J Ludwig, E R Dickson.   

Abstract

Primary sclerosing cholangitis and primary biliary cirrhosis are chronic cholestatic syndromes that may be difficult to differentiate clinically. Destructive cholangitis occurs in both diseases and leads to similar clinical and biochemical abnormalities. Therefore, we compared the clinical, biochemical, immunologic, radiologic, and hepatic histologic features of these syndromes in two large groups of patients prospectively selected by predefined criteria. Primary biliary cirrhosis (n = 258) occurred predominantly in middle-aged women who were usually symptomatic with fatigue and pruritus, commonly had keratoconjunctivitis sicca, and often were hyperpigmented. Tests for antimitochondrial antibodies were always positive, usually in very high titer. Although the extrahepatic bile ducts were normal radiographically, smooth tapering and narrowing of the intrahepatic bile ducts was occasionally noted. Hepatic histology was diagnostic when a florid duct lesion was present. In contrast, primary sclerosing cholangitis (n = 60) occurred primarily in young men who were usually symptomatic with fatigue and pruritus and frequently had chronic ulcerative colitis. Tests for antimitochondrial antibodies were nearly always negative and cholangiography demonstrated abnormalities of the extrahepatic and intrahepatic bile ducts in all cases. Although hepatic histology was often compatible with the diagnosis, it was usually not diagnostic, and considerable overlap existed with the abnormalities seen in primary biliary cirrhosis. Likewise, biochemical tests of copper metabolism were similar in both syndromes. These results call attention to the differences and similarities in the clinicopathologic features of these two cholestatic syndromes and provide a basis for a rational diagnostic strategy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3880553     DOI: 10.1016/s0016-5085(85)80141-4

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  28 in total

1.  Asymptomatic primary sclerosing cholangitis with marked hepatic fibrosis.

Authors:  H Kawai; Y Aoyagi; M Nomoto; H Takizawa; Y Suzuki; A Hama; T Suda; T Takahashi; H Asakura
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

Review 2.  Primary sclerosing cholangitis.

Authors:  S A Mitchell; R W Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 3.  Primary sclerosing cholangitis: updates in diagnosis and therapy.

Authors:  Piero Portincasa; Michele Vacca; Antonio Moschetta; Michele Petruzzelli; Giuseppe Palasciano; Karel J van Erpecum; Gerard P van Berge-Henegouwen
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

4.  Raised histamine concentrations in chronic cholestatic liver disease.

Authors:  S D Gittlen; E S Schulman; W C Maddrey
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

5.  Antibodies to Ro/La, Cenp-B, and snRNPs antigens in autoimmune hepatitis of North America versus Asia: patterns of immunofluorescence, ELISA reactivities, and HLA association.

Authors:  S Parveen; S A Morshed; K Arima; M Nishioka; A J Czaja; W C Chow; H S Ng
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

6.  Patients, cells, and organelles: the intersection of science and serendipity.

Authors:  Nicholas F Larusso
Journal:  Hepatology       Date:  2011-05       Impact factor: 17.425

7.  A morphometric study of the hepatic arterioles in end-stage primary sclerosing cholangitis.

Authors:  M Isabel Fiel; Hamid R Sima; Amirabbas Azarian; Thomas D Schiano
Journal:  Virchows Arch       Date:  2014-11-22       Impact factor: 4.064

8.  Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.

Authors:  J A Snook; R W Chapman; K Fleming; D P Jewell
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

9.  Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.

Authors:  J A Goss; C R Shackleton; D G Farmer; W S Arnaout; P Seu; J S Markowitz; P Martin; R J Stribling; L I Goldstein; R W Busuttil
Journal:  Ann Surg       Date:  1997-05       Impact factor: 12.969

10.  Validation of coding algorithms for the identification of patients with primary biliary cirrhosis using administrative data.

Authors:  Robert P Myers; Abdel Aziz M Shaheen; Andrew Fong; Alex F Wan; Mark G Swain; Robert J Hilsden; Lloyd Sutherland; Hude Quan
Journal:  Can J Gastroenterol       Date:  2010-03       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.